Detailed insights on topical drug delivery market upcoming technologies, R&D activities, and product launches in the topical drug delivery market. The report analyzes the topical drug delivery market by product type, route of administration, facilities of use, and region. In-depth assessment of market strategies, geographical and business segments, and product portfolios of the leading players in the topical drug delivery market.
- Agency -.
Complete Report on Topical Drug Delivery Market spread across 144 Pages, Profiling 10 Companies and Supported with 87 Tables and 41 Figures is now available at www.rnrmarketresearch.com/topical-…arket-report.html .
The topical drug delivery market is expected to reach USD 125.88 Billion by 2021 from USD 92.40 Billion in 2016 at a CAGR of 6.4% during forecast period. Topical drug delivery market is categorized into hospitals and private clinics, health care settings, and other facilities of use such as research institutes and diagnostic centers.
Hospitals and private clinics segment is expected to be the major end-user in topical drug delivery market.
- Agency -.
- Hospitals and Private Clinics
- Ambulatory Surgery Centers (ASCs)
- Academic Institutes
- Medical Research Institutes
- Market Research and Consulting Firms
- Venture Capitalists
- Suppliers and Distributors of Topical Products
Topical drug delivery market is categorized on the basis of product type, route of administration, facilities of use, and region. Apart from comprehensive geographical analysis, product analysis, and market sizing, the report also provides a competitive landscape that covers growth strategies adopted by industry players in the last three years.
In addition, the company profiles comprise basic views on the key players and their product portfolios, developments, and strategies adopted.
North America expected to dominate global market in 2016, with U.S. accounting for a major share of this regional market.
High incidence of skin diseases (like psoriasis, eczema, and skin cancer), increasing inclination of patients towards pain-free drug delivery, launch of new topical products, & increasing focus of prominent players on strengthening their presence in North American market (through acquisitions and expansions) are expected to drive growth of this regional market.
Global Market Drivers
1 High Prevalence of Skin Diseases
2 Growing Preference for Topical Drug Delivery
3 High Incidence of Burn Injuries
4 Rising Incidence of Diabetes
5 Rising Geriatric Population
The topical drug delivery market is a fragmented market with several global as well as local players operating in various market segments. The key players in this market are Galderma S.A.
(Switzerland), GlaxoSmithKline plc. (U.K.), Valeant Pharmaceuticals International, Inc.
(Canada), Crescita Therapeutics Inc. (Canada), Medpharm (U.K.), 3M (U.S.), Bayer AG (Germany), Novartis AG (Switzerland), Janssen Global Services, LLC (U.S.), and Cipla (India).
In addition, the company profiles comprise basic views on the key players and their product portfolios, developments, and strategies adopted. The abovementioned market research data, current market sizes, and forecast of future trends will help key players and new entrants make informed decisions regarding product offerings, geographical focus, changes in strategic approach, R&D investments for innovations in products and technologies, and levels of output to remain successful.
Category: Market Research Publishers and RetailersCompany profile: RnRMarketResearch.com is an online database of market research reports offers in-depth analysis of over 5000 market segments. The library has syndicated reports by leading market research publishers across the globe and also offer customized market research reports for multiple industries.
For more information: